Apr 23, 2011 by MedCity NewsSt. Jude, Medtronic Execs Offer Different Views on JAMA Article's ImpactAn article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask.
Apr 22, 2011 by MedCity NewsBiogen Idec's MS Drug Appears to Have an EdgeTrial results give the company an advantage in oral MS treatments.
Apr 20, 2011 by MedCity NewsGrowing CRO Demand Boosts Outlook for KendleIt's been rough going lately for Kendle.
Apr 16, 2011 by MedCity NewsPozen Wins Injunction Blocking Generic Migraine DrugThe ruling against Par Pharmaceutical comes just in time for Pozen.
Apr 15, 2011 by MedCity NewsGSK to Shed Weight Loss Drug alli and 18 OthersGSK wants to focus on fast-growing "priority brands."
Apr 14, 2011 by MedCity NewsBiogen Idec Inks Biotech Blood Products Research Deal With AmunixThe exclusive, worldwide research collaboration agreement calls for both companies to jointly conduct preclinical research.
Apr 12, 2011 by MedCity NewsEndo Acquires Pelvic Care Firm American Medical SystemsEndo Pharma diversifies.
Apr 8, 2011 by MedCity NewsMedtronic to Combine Cardiac and Vascular Sales ForcesWhat does Medtronic's new sales strategy mean?
Apr 7, 2011 by MedCity News"Generic Wave" to Drive Cardinal Health's Profitability in Coming YearsThe "generic wave" of drugs is coming.
Apr 5, 2011 by MedCity NewsGSK in Emerging Markets: Why Sales Staff There Are Key to Global StrategyGSK has a good business strategy, but is it enough?
Apr 5, 2011 by MedCity NewsTranzyme Pharma's Public Offering Raises $48M, but IPO Has Little BounceHow is Tranzyme really doing?
